[Treatment of salivary gland malignancies].
Salivary gland carcinomas comprise a rare group of malignant tumors which are characterized by their histopathological diversity, variable clinical course, in particular with respect to the facial nerve. Surgical resection with or without adjuvant radiotherapy is the treatment of choice. Surgical procedures are depending on the pathohistological diagnosis and the clinical staging according to the TNM classification respectively. The present paper gives a short overview about the therapeutic modalities with malignant tumors of the salivary glands.
Klinische Abteilung Allgemeine HNO-Krankheiten, Universitätsklinik für Hals-, Nasen- und Ohrenkrankheiten, Medizinische Universität Wien, Wien, Austria. michael.formanek@meduniwien.ac.at
Michael
M
Formanek
D003131:Combined Modality Therapy; D005158:Facial Paralysis / Q000517:prevention & control; D006801:Humans; D037981:Neck Dissection; D009367:Neoplasm Staging; D010307:Parotid Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D011183:Postoperative Complications / Q000517:prevention & control; D018714:Radiotherapy, Adjuvant